glucose lowering phenotype
Evidence from:
primary |
all sources
Related entities (3)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| Fgf21 | protective_against | glucose lowering | — | 1 |
| Klb | associated_with | glucose lowering | — | 1 |
| tesaglitazar | regulates | glucose lowering | — | 1 |
Mentioned in (2)
Papers in which this entity is mentioned.
- The PPAR α / γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat. (2013)
- FGF21 promotes metabolic homeostasis via white adipose and leptin in mice. (2012)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| glucose lowering | phenotype | 2 | 2 |